Literature DB >> 9643744

Mass screening for lung cancer with mobile spiral computed tomography scanner.

S Sone1, S Takashima, F Li, Z Yang, T Honda, Y Maruyama, M Hasegawa, T Yamanda, K Kubo, K Hanamura, K Asakura.   

Abstract

BACKGROUND: The incidence of and mortality from lung cancer have increased steadily. Most lung cancers are not localised when first detected, but early detection is mandatory to improve prognosis. Since curable early cases are hard to visualise with conventional chest radiography, a new diagnostic means must be found. We assessed whether population-based mass screening with a spiral computed tomography scanner could contribute substantially to detection of smaller cancers, and decrease mortality.
METHODS: In 1996, we screened in a mobile unit 5483 individuals from the general population of Matsumoto, Japan, aged between 40 years and 74 years who had undergone annual chest radiography (miniature fluorophotography) and cytological assessment of sputum. All participants had a low-dose X-ray spiral computed tomography (CT) scan of the thorax; 3967 also underwent miniature fluorophotography. We compared smokers and non-smokers. Further assessments were done for probably benign but suspicious lesions; suspicion of cancer; and indeterminate small nodules by chest radiography and conventional CT, with additional transbronchial biopsy when possible. Thoracotomy was recommended when it was strongly suspected that the patients had lung cancer.
FINDINGS: 19 patients were diagnosed as having lung cancer--14 with suspicion of lung cancer, three with benign but suspicious lesions, and two with indeterminate small nodules. 18 cases were surgically confirmed, and one was clinically diagnosed. The mean size of lesions was 17 mm (range 6-47). In four of 19 patients, lung abnormality was seen on CT and miniature fluorophotography. The lung-cancer detection rate with CT was 0.48%, significantly higher than the 0.03-0.05% for standard mass assessments done previously in the same area. CT missed one case that was found solely on a sputum cytology examination.
INTERPRETATION: Our results show that miniature fluorophotography or conventional chest radiography, which have been the main diagnostic techniques for lung cancer, showed few small cancers. CT was more accurate in mass screening for lung cancer and led to early detection and an accurate diagnosis of lung cancer, and should be considered in future health plans.

Entities:  

Mesh:

Year:  1998        PMID: 9643744     DOI: 10.1016/S0140-6736(97)08229-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  146 in total

Review 1.  Biomarkers as surrogates for cancer development.

Authors:  E Hawk; J L Viner; J A Lawrence
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

Review 2.  Spiral computed tomography screening: study begins to determine its efficacy in lung cancer prevention.

Authors:  B S Kramer
Journal:  West J Med       Date:  2001-04

Review 3.  Detection of early lung cancer.

Authors:  J C Porter; S G Spiro
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

4.  New arrangements for NHS R&D funding: implications for primary care research.

Authors:  Roger Jones; Yvonne Carter; Sean Hilton
Journal:  Br J Gen Pract       Date:  2002-01       Impact factor: 5.386

5.  Cancer recognition and primary care.

Authors:  Nicholas Summerton
Journal:  Br J Gen Pract       Date:  2002-01       Impact factor: 5.386

6.  Misinterpretation of the chest x ray as a factor in the delayed diagnosis of lung cancer.

Authors:  P M Turkington; N Kennan; M A Greenstone
Journal:  Postgrad Med J       Date:  2002-03       Impact factor: 2.401

Review 7.  Issues at the interface between primary and secondary care in the management of common respiratory disease. 1. The challenge of improving the delivery of lung cancer care.

Authors:  M F Muers; W F Holmes; C Littlewood
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

8.  Screening for cancer with computed tomography.

Authors:  Stephen J Swensen
Journal:  BMJ       Date:  2003-04-26

9.  High thymidine kinase 1 (TK1) expression is a predictor of poor survival in patients with pT1 of lung adenocarcinoma.

Authors:  Yan Xu; Qun-Li Shi; Henghui Ma; Hangbo Zhou; Zhenfeng Lu; Bo Yu; Xiaojun Zhou; Staffan Eriksson; Ellen He; Sven Skog
Journal:  Tumour Biol       Date:  2011-12-06

10.  Diagnostic performance of percutaneous lung biopsy using automated biopsy needles under CT-fluoroscopic guidance for ground-glass opacity lesions.

Authors:  T Yamagami; R Yoshimatsu; H Miura; K Yamada; A Takahata; T Matsumoto; T Hasebe
Journal:  Br J Radiol       Date:  2013-02       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.